CN Patent

CN104470516A — 鼻内右美托咪定组合物和其使用方法

Assigned to Recro Pharma Inc · Expires 2015-03-25 · 11y expired

What this patent protects

本发明提供包含右美托咪定或其药用盐的鼻内制剂，它们是镇痛剂而无显著镇静作用；治疗或预防疼痛的方法，包括将该鼻内制剂给予至哺乳动物；及其用于以喷雾给予该鼻内制剂的定量装置，其中，该喷雾的液滴具有小于150μm的Dv90。

USPTO Abstract

本发明提供包含右美托咪定或其药用盐的鼻内制剂，它们是镇痛剂而无显著镇静作用；治疗或预防疼痛的方法，包括将该鼻内制剂给予至哺乳动物；及其用于以喷雾给予该鼻内制剂的定量装置，其中，该喷雾的液滴具有小于150μm的Dv90。

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN104470516A
Jurisdiction: CN
Classification: —
Expires: 2015-03-25
Drug substance claim: No
Drug product claim: No
Assignee: Recro Pharma Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.